Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy

Menopause

Volumn 19, Issue 4, 2012, Pages 471-475

  Rogines Velo, Maria Pia ^a   Heberle, Amy E ^a   Joffe, Hadine ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Depression; Estradiol; Medroxyprogesterone; Menopause; Perimenopause; Women

Indexed keywords

ESTRADIOL; FOLLITROPIN; MEDROXYPROGESTERONE; PLACEBO; ZOLPIDEM;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CLIMACTERIUM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYSTERECTOMY; NONPARAMETRIC TEST; OPEN STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP QUALITY; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; DEPRESSION; FEMALE; HEALTH STATUS; HOT FLASHES; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PERIMENOPAUSE; POSTMENOPAUSE; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 84859429717     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182333847     Document Type: Article

References (31)

1. Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 1999; 6:282-289. (Pubitemid 30003270)
2. Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause 2000;7:273-281. (Pubitemid 30445958)
3. Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. Am J Med 2005;118:163-165.
4. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414-420. (Pubitemid 30651090)
5. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a doubleblind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58:529-534. (Pubitemid 32523731)
6. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212. (Pubitemid 27293623)
7. Andreen L, Bixo M, Nyberg S, Sundstrom-Poromaa I, Backstrom T. Progesterone effects during sequential hormone replacement therapy. Eur J Endocrinol 2003;148:571-577. (Pubitemid 36622166)
8. Andreen L, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom T. Allopregnanolone concentration and moodVa bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) 2006;187:209-221. (Pubitemid 44015615)
9. Hammarback S, Backstrom T, Holt J, et al. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestogen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985;64: 393-397. (Pubitemid 15226881)
10. Holst J, Backstrom T, Hammarback S, von Schoultz B. Progestogen addition during oestrogen replacement therapyVeffects on vasomotor symptoms and mood. Maturitas 1989;11:13-20. (Pubitemid 19076761)
11. Natale V, Albertazzi P, Zini M, Di Micco R. Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations. BJOG 2001; 108:286-290. (Pubitemid 32210129)
12. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-343. (Pubitemid 21921696)
13. Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Neuropsychobiology 2005;52:17-23. (Pubitemid 40910945)
14. Kirkham C, Hahn PM, Van Vugt DA, Carmichael JA, Reid RL. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy. Obstet Gynecol 1991;78:93-97.
15. Siddle NC, Fraser D, Whitehead MI, et al. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone. Br J Obstet Gynaecol 1990;97:1101-1107.
16. Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A. A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas 2004;48:456-462. (Pubitemid 38993261)
17. Cummings JA, Brizendine L. Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women. Menopause 2002;9:253-263. (Pubitemid 34743450)
18. Prior JC, Alojado N, McKay DW, Vigna YM. No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, crossover trial [see comments]. Obstet Gynecol 1994;83:24-28. (Pubitemid 24027375)
19. Avis N, Brambilla D, McKinlay S, Vass K. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4:214-220. (Pubitemid 24154300)
20. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385-390.
21. Joffe H, Hall J, Soares C, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-398. (Pubitemid 36706332)
22. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med 2011;41:1879-1888.
23. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
24. Joffe H, Petrillo LF, Koukopoulos A, et al. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 2011;96:E1044-1054.
25. Joffe H, Hall JE, Gruber S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006;13:411-422.
26. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878. (Pubitemid 33031310)
27. First M, Spitzer R, Gibbom M, Williams J. Structured Clinical Interview for DSM-IV Axis I DisordersVPatient Edition (SCID-I/P Version 2.0). New York, NY: New York State Psychiatric Institute Biometrics Research Department, 1995.
28. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389. (Pubitemid 9136500)
29. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
30. Association AP. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association Press, Inc., 2000.
31. Bjorn I, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom G, Backstrom T. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clin Endocrinol Metab 2003;88:2026-2030. (Pubitemid 36553110)